Clozapine-associated elevation of plasma cholinesterase

European Archives of Psychiatry and Clinical Neuroscience

Volumn 251, Issue 6, 2001, Pages 269-271

  Wiltfang, Jens ^a   Schenk Daprá, Bettina ^a   Stiens, Gerthild ^a   Bleich, Stefan ^a   Bandelow, Borwin ^a   Müller, Peter ^a   Niedmann, Paul Dieter ^b   Armstrong, Victor William ^b   Rüther, Eckart ^a  

^a Department of Psychiatry and Psychotherapy ^*  (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Clozapine; Lipid metabolism; Liver function

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CHOLINESTERASE; CLOZAPINE; NORCLOZAPINE; PSYCHOTROPIC AGENT; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; LIPID METABOLISM; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0035712476     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007544     Document Type: Article

References (7)

1. Clinical efficacy of clozapine in treatment- refractory schizophrenia: An overview
2. Fatal acute fulminant liver failure due to clozapine: A case report and review of clozapine-induced hepatotoxicity
3. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
4. Antipsychotic-induced weight gain: A comprehensive research synthesis
5. Enzymes
6. Eine kinetische methode zur bestimmung der aktivität der pseudocholinesterase (acylcholinacylhydrolase 3.1.1.8)
7. Clozapine: A review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents